Roche receives CE mark for mySugr, Accu-Check integration
By HME News Staff
Updated 9:26 AM CDT, Thu September 18, 2025
BASEL, Switzerland – Roche has received the CE mark of approval for the integration of the mySugr app with its Accu-Chek SmartGuide and is set to launch it later this year. Users can view and analyze their CGM glucose values and predictions in one place, alongside other mySugr app functionalities, such as taking photos of and logging meals in the app to better understand blood glucose level patterns, seeing data from other connected devices and using the mySugr Bolus Calculator to help with insulin calculations. "The Accu-Chek SmartGuide CGM solution is a significant step toward providing greater peace of mind for people living with diabetes due to the AI-enabled predictive capabilities it offers,” said Rodrigo Diaz de Vivar, Lifecycle Leader Patient Insights, Roche Diagnostics. “This empowers patients to take action before undesired events occur. By bringing together our Accu-Chek SmartGuide solution with mySugr, we are combining our predictive CGM technology with one of the world's most popular diabetes management apps that has more than 6 million registered accounts. This integration offers a comprehensive tool that simplifies daily decision-making by visualizing and analyzing all their therapy data in one place."
Comments